|
Name |
5,3',4'-Trihydroxy-3-methoxy-6,7-methylenedioxyflavone
|
Molecular Formula | C17H12O8 | |
IUPAC Name* |
6-(3,4-dihydroxyphenyl)-9-hydroxy-7-methoxy-[1,3]dioxolo[4,5-g]chromen-8-one
|
|
SMILES |
COC1=C(OC2=CC3=C(C(=C2C1=O)O)OCO3)C4=CC(=C(C=C4)O)O
|
|
InChI |
InChI=1S/C17H12O8/c1-22-17-14(21)12-10(5-11-16(13(12)20)24-6-23-11)25-15(17)7-2-3-8(18)9(19)4-7/h2-5,18-20H,6H2,1H3
|
|
InChIKey |
BBZORTSKYSEICL-UHFFFAOYSA-N
|
|
Synonyms |
5,3',4'-Trihydroxy-3-methoxy-6,7-methylenedioxyflavone; SCHEMBL17938762; CHEBI:188082; LMPK12113020; 3-methoxy-6,7-methylenedioxy-5,3' ,4'-trihydroxyflavone; 6-(3,4-Dihydroxyphenyl)-7-methoxy-9-hydroxy-8H-1,3-dioxolo[4,5-g][1]benzopyran-8-one; 6-(3,4-dihydroxyphenyl)-9-hydroxy-7-methoxy-[1,3]dioxolo[4,5-g]chromen-8-one
|
|
CAS | NA | |
PubChem CID | 44259872 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 344.3 | ALogp: | 2.7 |
HBD: | 3 | HBA: | 8 |
Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 115.0 | Aromatic Rings: | 4 |
Heavy Atoms: | 25 | QED Weighted: | 0.607 |
Caco-2 Permeability: | -4.915 | MDCK Permeability: | 0.00001550 |
Pgp-inhibitor: | 0.995 | Pgp-substrate: | 0 |
Human Intestinal Absorption (HIA): | 0.007 | 20% Bioavailability (F20%): | 0.002 |
30% Bioavailability (F30%): | 0.007 |
Blood-Brain-Barrier Penetration (BBB): | 0.005 | Plasma Protein Binding (PPB): | 94.88% |
Volume Distribution (VD): | 0.671 | Fu: | 10.22% |
CYP1A2-inhibitor: | 0.925 | CYP1A2-substrate: | 0.376 |
CYP2C19-inhibitor: | 0.41 | CYP2C19-substrate: | 0.058 |
CYP2C9-inhibitor: | 0.743 | CYP2C9-substrate: | 0.72 |
CYP2D6-inhibitor: | 0.633 | CYP2D6-substrate: | 0.302 |
CYP3A4-inhibitor: | 0.607 | CYP3A4-substrate: | 0.093 |
Clearance (CL): | 11.131 | Half-life (T1/2): | 0.774 |
hERG Blockers: | 0.041 | Human Hepatotoxicity (H-HT): | 0.058 |
Drug-inuced Liver Injury (DILI): | 0.976 | AMES Toxicity: | 0.679 |
Rat Oral Acute Toxicity: | 0.211 | Maximum Recommended Daily Dose: | 0.044 |
Skin Sensitization: | 0.742 | Carcinogencity: | 0.698 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.911 |
Respiratory Toxicity: | 0.128 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003106 | 0.520 | D0K8KX | 0.512 | ||||
ENC001529 | 0.512 | D04AIT | 0.422 | ||||
ENC001751 | 0.462 | D06GCK | 0.390 | ||||
ENC002625 | 0.453 | D07MGA | 0.337 | ||||
ENC001573 | 0.440 | D02FCQ | 0.324 | ||||
ENC005391 | 0.434 | D04TDQ | 0.314 | ||||
ENC001534 | 0.422 | D0L1JW | 0.304 | ||||
ENC002471 | 0.422 | D0AZ8C | 0.292 | ||||
ENC001772 | 0.418 | D0W8WB | 0.288 | ||||
ENC001548 | 0.407 | D0D4HN | 0.281 |